It is one of the great scandals of our time.
Drax, which generates electricity by burning trees imported as pellets from North America, is more expensive than gas, more polluting than coal and more dependent on imports than oil.
Yet it is, incredibly, designated as ‘sustainable biomass’, pocketed £870m in subsidies last year and will likely trouser another 2 billion subsidies over the next four years – all to allow Ed ‘The Zealot’ Miliband to include Drax in his net zero calculations.
Not just a scandal but an expensive scandal for the taxpayer.
🎉 Congratulations to Dr. Sarah Svenningsen, Dr. Parameswaran Nair, and colleagues on the publication of “Ventilation defect burden predicts lung cancer resection outcomes” in @ERSpublications ERJ Open Research!
When it comes to lung cancer resection, pre-operative ventilation defects can be a critical warning sign—and this new study highlights why.
The research shows that ventilation defect percentage (VDP), measured by #XenonMRI—even when lung function as measured by current diagnostics appears normal—can more accurately predict post-operative complications and extended hospital stays
A surprising and important finding was that many patients without any history of obstructive lung disease actually had underlying abnormal lung function. By revealing ventilation defects that are not visible in traditional measures, Xenon MRI can better assess risk factors and enable more tailored surgical planning.
We’re proud to celebrate this milestone, which underscores the clinical and economic value of functional imaging with Xenon MRI in meaningful clinical outcomes—advancing #surgicaloncology care for patients with lung cancer.
📖 Read the article: https://t.co/NrKpn849nP
#LungCancer #ThoracicSurgery #MRI #Radiology #PulmonaryImaging #LungResection #CancerCare
#ANGLE’s Parsortix® system uses a patented microfluidic technology in the form of a single use cassette to capture and then harvest circulating tumour cells (CTCs) from whole blood.
Discover more here: https://t.co/Sarf7gEKmh
#CancerResearch#ANGLEplc#LiquidBiopsy#CTC
📰 NEWS: The founder of a company dedicated to improving outcomes for #cancer patients though liquid biopsy blood tests has shared his views on why live cell liquid biopsies should become standard in #oncology practice
@Parsortix
🔗 Read more: https://t.co/fDiRPhWZ0s
I can't believe what I've just watched?!
The UK has the most expensive energy costs in the world, and Ed Miliband REFUSES to accept that taxes and Net Zero levies impact the price of energy.
The man is a colossal idiot and a liar!
Absolute car crash.
As market volatility continues, here is Warren Buffett living it up with a $300 billion cash pile & 4.6% of the entire U.S. Treasury Bill Market.
US taxpayers are paying Buffett $12.6bn in annual interest on his $286 billion of Treasury Bill holdings.
Cancer immunotherapies are considered a game-changers and the future of cancer treatments, however Cytokine Release Syndrome, a potentially life-threatening condition, is a knock-on effect which affects 70% of patients receiving certain cancer-#immunotherapy treatments.
Despite these treatments being considered as “game-changers” there is a high medical unmet need to address the CRS so that immunotherapies can be safer and more accessible for #patients, that’s where POLB 001 comes in.
POLB 001 is a potent and selective p38 #MAPK inhibitor and is orally administered. With excellent safety and tolerability profile, POLB 001 selectively targets excessive #inflammation, caused by #CRS.
The strong patent portfolio that we have put in place to protect the intellectual property of #POLB 001 across multiple locations worldwide, coupled with the positive endorsement received from key opinion leaders, underscores our commitment to advance this asset – not only to help patients, but to contribute to the future of immunotherapies and #healthcare innovation by expanding access to these life-saving therapies.
Learn more:
https://t.co/xDBLqtZIB4
Mark Routh, CEO of Prospex Energy, and Dennis Donald, CEO of Warrego Energy, are pictured here formalising the completion of Prospex Energy’s acquisition of 100% of Tarba Energía.
Read the full RNS here: https://t.co/WdJNbQ99nD
Big news for UK clinical trials as the Clinical Trials Amendment Regulations 2024 have been passed as law, which is the most significant update in 20 years.
At hVIVO, we welcome these changes that put patient safety, transparency, and streamlined approvals at the forefront of research.
With a 12-month transition period, we're already aligning with the new framework to continue delivering trusted, high-quality trials from our state-of-the-art facility in Canary Wharf.
Learn more:
https://t.co/ad2yJxe2SA
#HVO #ClinicalTrials #UKResearch #MHRA #HRA #LifeSciences #Innovation #HCT
‘Did you ask him to speak English?
….Because if you did, that could be perceived as a hate crime’
(No says the deaf man, I asked him to speak clearly as I couldn’t understand him).
Give me strength.
What is actually happening to this country?
🤡🌎
Anyone have a sense of déjà vu?
Because it appears Chancellor @RachelReevesMP is falling into the same 'uncertainty' trap as prior to the October Budget.
Everyone knows the government needs to pull some new austerity &/or tax raising levers in her 26th March Spring Budget (see below). Which (surprise, surprise) is unsettling business & consumer confidence again, alongside delaying investment decisions.
Hence this time, what about instead perhaps engendering some serious productivity improvements across the public sector?
Maybe even addressing some public sector 'sacred cows' like removing top rate tax relief on pension contributions (est £10bn pa saving)?
Similarly, don't stuff the private sector again! If the country needs growth & fresh capital to fund public services - then please help these guys out, rather than hammering them!
https://t.co/dn3ghmpxyd
'Specialist subject: all the corrections that Rachel Reeves has made to her CV'
My latest cartoon for tomorrow's @Telegraph
Buy a print of my cartoons at https://t.co/ILFJjPmckx
Original artwork from https://t.co/bVPAkgE34y
@MBdaytrading@ProspexEnergy This is how Heyco Energy roll
They already have 10% stake in @ProspexEnergy
Will be interesting to see if they have bigger plans for the Italy & Spain assets